Non-autologous mesangioblasts (San Raffaele Scientific Institute)

N/A

Report date: 2025/04/10 17:28:17

Base Information

Drug NameNon-autologous mesangioblasts (San Raffaele Scientific Institute)
Drug Alias Namedonor muscle progenitor stem cell therapy (Duchenne muscular dystrophy)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Muscle stem cell therapy
Mechanisms of ActionStem cells stimulants
TargetsNot applicable
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSan Raffaele Scientific Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSan Raffaele Scientific Institute
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophy, Duchenne

Other Information

ATC CodeN/A
Related LinksN/A